HomeEVAX • NASDAQ
Evaxion Biotech A/S - ADR
add
$1.71
2.02%
Pre-market:(1.43%)-0.025
$1.69
Closed: May 22, 12:31:08 AM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 122.00K | 67.12% |
Operating expense | 4.15M | -6.56% |
Net income | -3.63M | 19.77% |
Net profit margin | -2.97K | 51.99% |
Earnings per share | -0.07 | 99.13% |
EBITDA | -3.93M | 7.92% |
Effective tax rate | 7.04% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.95M | 6.61% |
Total assets | 12.49M | -3.13% |
Total liabilities | 14.14M | -19.76% |
Total equity | -1.65M | — |
Shares outstanding | 6.27M | — |
Price to book | -1.48 | — |
Return on assets | -72.71% | — |
Return on capital | -85.13% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -3.63M | 19.77% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
$1.75
Day range
$1.70 - $1.86
Year range
$1.20 - $20.81
Market cap
10.83M USD
Avg Volume
66.70K
Primary exchange
NASDAQ
About
Founded
2008
Website
Employees
46